1,841 reports of this reaction
4.1% of all BIMATOPROST reports
#4 most reported adverse reaction
EYE IRRITATION is the #4 most commonly reported adverse reaction for BIMATOPROST, manufactured by Allergan, Inc.. There are 1,841 FDA adverse event reports linking BIMATOPROST to EYE IRRITATION. This represents approximately 4.1% of all 44,865 adverse event reports for this drug.
Patients taking BIMATOPROST who experience eye irritation should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
EYE IRRITATION is moderately reported among BIMATOPROST users, representing a notable but not dominant share of adverse events.
In addition to eye irritation, the following adverse reactions have been reported for BIMATOPROST:
The following drugs have also been linked to eye irritation in FDA adverse event reports:
EYE IRRITATION has been reported as an adverse event in 1,841 FDA reports for BIMATOPROST. This does not prove causation, but indicates an association observed in post-market surveillance data.
EYE IRRITATION accounts for approximately 4.1% of all adverse event reports for BIMATOPROST, making it a notable side effect.
If you experience eye irritation while taking BIMATOPROST, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.